Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM52PE
HR+
Luminal
Disulfiram
Proteasome
Proteasome
12969.174
uM
12.06230
475.56020
0.1360 -1.0000 0.2990 0.2230
0.7865
1.1194
SUM52PE
HR+
Luminal
Disulfiram
Proteasome
Proteasome
13570.174
uM
inf
0.04829
0.7255 0.6325 4.7807 0.2216
0.7871
0.5197
SUM52PE
HR+
Luminal
Docetaxel
TUBB
TUBB
12969.002
uM
0.00197
0.00104
0.1240 0.1207 0.4307 0.5928
0.7473
1.0653
SUM52PE
HR+
Luminal
Docetaxel
TUBB
TUBB
9878.002
uM
0.00219
0.00315
-0.3020 -0.2924 1.2701 0.8102
0.9880
1.3437
SUM52PE
HR+
Luminal
Docetaxel
TUBB
TUBB
9889.002
uM
0.00130
0.00174
-0.3619 -0.3400 1.7739 0.9146
0.9936
1.1879
SUM52PE
HR+
Luminal
Doxorubicin
TOP2
TOP
9889.034
uM
0.08331
0.14745
-0.8893 -0.5445 1.2903 0.7318
0.9567
1.3742
SUM52PE
HR+
Luminal
Doxorubicin
TOP2
TOP
7540.078
uM
0.12817
0.16578
-0.9997 -0.8307 3.8038 0.8677
0.9932
0.9523
SUM52PE
HR+
Luminal
Epirubicin
TOP2
TOP
7923.017
uM
0.00162
0.03188
-0.9999 -1.0000 0.3688 1.3173
0.790
0.6267
SUM52PE
HR+
Luminal
Epirubicin
TOP2
TOP
9878.017
uM
0.30083
0.45917
-0.9967 -0.6770 2.0246 0.7526
0.9685
1.3463
SUM52PE
HR+
Luminal
Erlotinib
EGFR
ErbB
7540.09
uM
inf
inf
-0.0311 -0.0311 0.0000 0.3195
0.4818
0.5702
SUM52PE
HR+
Luminal
Erlotinib
EGFR
ErbB
7541.091
uM
55.96950
95.19380
0.3900 -0.7153 1.6722 0.0421
0.9360
1.4119
SUM52PE
HR+
Luminal
Erlotinib
EGFR
ErbB
7539.092
uM
12.30920
11.93560
0.0733 0.0628 4.3571 0.0841
0.9766
1.2233
SUM52PE
HR+
Luminal
Etoposide
TOP2
TOP
7541.074
uM
2.57960
4.42740
-0.5256 -0.4690 1.2247 0.4922
0.9923
1.3223
SUM52PE
HR+
Luminal
Everolimus
MTOR
MTOR
11852.156
uM
0.01372
0.85090
-0.9736 -1.0000 0.2662 0.7618
0.7760
1.0109
SUM52PE
HR+
Luminal
Fascaplysin
CDK4
CDK
7541.084
uM
0.21080
0.39949
-0.9703 -0.9992 1.7177 0.7205
0.9913
1.2092
SUM52PE
HR+
Luminal
FR180204
ERK1/2
MAPK
10695.149
uM
86.4740
40.52320
0.6748 0.2751 1.0539 0.0440
0.8238
1.3252
SUM52PE
HR+
Luminal
FR180204
ERK1/2
MAPK
11852.161
uM
40.46870
29.18790
0.2988 0.2250 1.8292 0.0858
0.9627
1.5680
SUM52PE
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
11852.154
uM
8.83230
7.87840
0.2108 0.2100 4.7656 0.0991
0.9282
1.2816
SUM52PE
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
10695.154
uM
19.78620
45.25810
0.2100 -0.9668 1.3007 0.0780
0.9755
1.4756
SUM52PE
HR+
Luminal
Gefitinib
EGFR
ErbB
7923.016
uM
inf
inf
-0.8122 -0.8122 0.0000 1.1063
-0.0557
0.6280
SUM52PE
HR+
Luminal
Gefitinib
EGFR
ErbB
7540.016
uM
8.32790
8.00520
0.0903 0.0896 4.9971 0.1567
0.8380
0.9455
SUM52PE
HR+
Luminal
Gefitinib
EGFR
ErbB
9878.019
uM
8.80480
9.32790
-0.1460 -0.1495 4.5342 0.1215
0.9879
1.4790
SUM52PE
HR+
Luminal
Geldanamycin
HSP90
HSP90
9889.012
uM
0.01345
0.01458
-0.3687 -0.1222 2.7132 0.7451
0.9620
1.3671
SUM52PE
HR+
Luminal
Geldanamycin
HSP90
HSP90
9878.012
uM
0.00869
0.01198
-0.3961 -0.3029 1.4774 0.9011
0.9907
1.2431
SUM52PE
HR+
Luminal
Gemcitabine
DNA replication
DNA replication
9878.011
uM
0.00732
0.00992
-0.4142 -0.1960 1.0863 0.8674
0.9254
1.2938